In this study, we determined the dynamic expression of TIPE2 mRNA in PBMCs in different stages of HBV-associated liver diseases and identified the potential diagnostic value of TIPE2 mRNA as a biomarker for discriminating HBV-associated HCC from CHB and LC patients. The gene discussed is TIPE2; the disease is laryngotracheoesophageal cleft.